Become a part of our success!
Our vision is to create a world where cancer is diagnosed early and treated successfully. We are pleased to announce that we have launched a new investment campaign in which Slovak (as well as foreign) investors can become part of our story. On the Crowdberry platform you can find more information about our achievements so […]
EIC & EuroQuity – Bpifrance Healthcare Investor Day
It was my great pleasure to present Glycanostics® and our early-stage cancer diagnostic test Giasay® at the EIC & EuroQuity – Bpifrance Healthcare Investor Day on 23 October in Paris. It was a great opportunity to meet expert investors looking for the best biotech, pharma, eHealth and medtech companies and take our fundraising journey one step further. Great thanks to the organizers European Innovation Council […]
HealthTech Innovation Days (HTID) – HealthTech For Care
„Glycanostics® is going to be one of 25 most innovative companies that will compete at a pitch competition at the HealthTech Innovation Days (HTID®) in Paris. Please meet our CEO Eva Kovacova in Paris to discuss future of non-invasive cancer diagnostics based on analysis of glycans.” HealhTech Innovation Days (HTID) – HealthTech For Care
European Angel Investment Summit 2023
Meet our CEO Eva Kovacova FCCA at the European Angel Investment Summit in Brussels on 10-11 October! Join me at the premier annual conference where angels, entrepreneurs, and change-makers come together to fuel Europe’s growth: https://lnkd.in/e4MYq4-9 #EAIS23 offers a glimpse into the future, an opportunity to shape tomorrow’s course, and a unique platform to connect with international colleagues who bring […]
We are expanding the network of cooperating urologists
The network of urologists who provide the Giasay® PROSTATE test is gradually expanding. Today, you can take the highly accurate prostate cancer test at specialist urology clinics in four regional and five district cities. Please visit.
EUROPEAN PATENT – EP3775909
First Patent Certificate for EP Patent No. 3 775 909 for us! Availabe here.
New project: € 2.5 mil. funding signed for Novel serological glycan-based biomarkers for screening of breast, lung and pancreatic cancers
The Glycanostics cancer screening technology detects glycan changes (complex carbohydrates) attached to a protein in the blood. It is highly scalable due to the following unique characteristics: detects early-stage cancers that can be missed with imaging techniques (small tumours too); gives quantitative & qualitative info, so we can monitor the disease progress; is affordable, no […]
European Female Founders Summit
8th & 9th March, 2023, Brussels Our CEO Eva Kováčová is one of the organisers of the first summit by the EU Female Founders in Brussels under the sponsorship of EU Commissioner Mariya Gabriel. Meet us there to make Europe a better place for female founders!
ISO 13485
Glycanostics took another important step to improve its quality management system and has been granted with ISO 13485.
